FDA takes ZANTAC off the market due to cancer risk – you may be eligible for compensation for use of ZANTAC

Did you develop cancer after prolonged use of heartburn and acid-reducing medications like Zantac or its generic forms, otherwise known as Ranitidine?

If so, please contact our experienced product liability attorneys ( to get latest information on whether you may be entitled to compensation.


The Federal Drug Administration (FDA) first alerted patients and health care professional of potential risks of cancer caused by Ranitidine in September 2019. Sanofi, a pharmaceutical company and manufacture of ZANTAC announced a voluntary recall due to its concerns of a potential dangerous cancer-causing chemical knows as N-nitroso dimethylamine or NDMA.

On April 1, 2020, the FDA recalled ZANTAC and Ranitidine from the market entirely see:

NDMA was once used in the production of rocket fuel and is primarily used to induce cancer in laboratory mice for study. The international Agency for Research on Cancer (IARC) has classified NDMA as a B2 (probably human) Carcinogen. It is also known as a potent hepatotoxin which can cause liver damage. According to recent testing done by the FDA on ranitidine samples from various drug manufacturers, more than half of the 18 samples tested contained unacceptably high levels of NDMA (more than 0.32 parts per million (ppm) of NDMA).


If you, a friend or a loved one have been diagnosed with one of the types of cancers listed below after having take ZANTAC or its generic form, either prescription strength or “over the counter”, for six months to a year, at least once a week, and have received a cancer diagnosis, you have a claim. Symptoms of NDMA exposure include headaches, fever, jaundice, abnormal cramps, enlarged liver, reduced organ function and dizziness.

Epidemiological studies continue to determine which cancers were caused by NDMA exposure from ZANTC or Ranitidine but presently the types of cancer include:

  • Liver Cancer
  • Colon Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Stomach Cancer
  • Esophageal/Throat/Nasal Cancer
  • Brain Cancer * Prostate Cancer
  • Testicular Cancer
  • Pediatric Testicular Cancer
  • Non-Hodgkin’s Lymphoma
  • Prostate Cancer
  • Breast Cancer * Lung Cancer
  • Ovarian Cancer * Pancreatic Cancer


If you feel you, a loved one or friend may be eligible to make a legal claim for compensation as a result of being diagnosed with a cancer listed above after taking ZANTAC or one of its generic forms, please contact YUHL | CARR by calling our office or sending an email to (